Non-Hodgkin's lymphoma

• Autores: Lisa Lowry, David Linch
• Localización: Medicine, ISSN-e 1357-3039, Vol. 41, Nº. 5, 2013, págs. 282-289
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Non-Hodgkin's lymphoma (NHL) is the fifth most common cancer in the UK, and represents a heterogeneous group of malignancies. This article will give an overview of lymphoid neoplasms, concentrating on the common subtypes of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). Clinical outcomes in B-cell NHL have significantly improved in the past decade, largely due to the availability of the monoclonal antibody, rituximab. However, some aggressive lymphomas, including many T-cell disorders, still carry a poor prognosis.